2024-12-14 00:37:34
IDC: The global market for sweeping robots continued to grow in the third quarter. According to IDC's Quarterly Tracking Report on the Global Smart Home Equipment Market, the third quarter of 2024, the global market for intelligent sweeping robots shipped 5.014 million units in the third quarter, up 11.1% year-on-year. Among them, the domestic market was boosted by the trade-in of old models at the end of September, with 1.321 million units shipped, up by 17% year-on-year, and the efforts of most provinces were around 20%, which significantly stimulated the shipment of high-end models, and this trend also continued to this year's "Double Eleven". The proportion of overseas sales of China manufacturers continues to increase, and the competition of high-end all-around models in European and American markets is still fierce.CMB International: Upgraded the target price of WuXi Bio to HK$ 22.88, optimistic about the company's valuation and performance repair. CMB International published a report, predicting that the US Biosafety Act will fail with high probability, which will help WuXi Bio to achieve continuous performance growth in a relatively stable business environment. With the recovery of global biomedical financing, we are optimistic about the company's valuation and performance repair. According to the report, the NDAA in FY 2025 does not include the Biosafety Act, and the legislation of the Biosafety Act failed with high probability. On December 7, the US Senate and the House Armed Services Committee announced the National Defense Authorization Act (NDAA) for fiscal year 2025, which was finally negotiated by the committees of the two houses. The Biosafety Act was not included in the amendment of NDAA in FY 2025, which means that the Biosafety Act failed to pass the legislative path of joining NDAA. The Biosafety Act can still promote separate legislation, but considering that the window of the current US Congress session is less than two weeks, the Bank believes that the success rate of separate legislation is extremely low. CMB International maintained the "Buy" rating of Yaoming Bio, and its target price rose from HK$ 13.58 to HK$ 22.88. It is estimated that the company's revenue will increase by 7.1%/12.4%/ 13.9% from 2024 to 2026, and its adjusted net profit will increase by 0.8%/11.1%/13.4% respectively.On the 13th, local time, the South Korean prosecutor summoned Guo Zhonggen, the commander of the special operations before the investigation.
Zhongkong Technology won the bid for the whole plant control system project of Rong Sheng New Materials and held a kick-off meeting. Recently, Zhongkong Technology successfully won the bid for the whole plant control system framework project of Jintang New Materials Project of Rong Sheng New Materials (Zhoushan) Co., Ltd. (hereinafter referred to as "Jintang New Materials Project") and held a kick-off meeting in Zhongkong Science Park. The project is expected to deploy 360,000-point I/O DCS system, 15,000-point SIS system and 10,000-point GDS system. At the same time, a number of new products and technologies that occupy the forefront of the industry, such as UCS products of central control technology, SmartEIO, million-point real-time database and calorific value analysis, will also be applied on a large scale in this project, helping Jintang new materials to build a world-leading intelligent factory.Research shows that the French "online celebrity" economy will earn nearly 6.5 billion euros in 2024. A research report released in Paris recently shows that the French "online celebrity" economy will earn nearly 6.5 billion euros in 2024, accounting for 0.16% of the country's gross domestic product (GDP).CMB International: Upgraded the target price of WuXi Bio to HK$ 22.88, optimistic about the company's valuation and performance repair. CMB International published a report, predicting that the US Biosafety Act will fail with high probability, which will help WuXi Bio to achieve continuous performance growth in a relatively stable business environment. With the recovery of global biomedical financing, we are optimistic about the company's valuation and performance repair. According to the report, the NDAA in FY 2025 does not include the Biosafety Act, and the legislation of the Biosafety Act failed with high probability. On December 7, the US Senate and the House Armed Services Committee announced the National Defense Authorization Act (NDAA) for fiscal year 2025, which was finally negotiated by the committees of the two houses. The Biosafety Act was not included in the amendment of NDAA in FY 2025, which means that the Biosafety Act failed to pass the legislative path of joining NDAA. The Biosafety Act can still promote separate legislation, but considering that the window of the current US Congress session is less than two weeks, the Bank believes that the success rate of separate legislation is extremely low. CMB International maintained the "Buy" rating of Yaoming Bio, and its target price rose from HK$ 13.58 to HK$ 22.88. It is estimated that the company's revenue will increase by 7.1%/12.4%/ 13.9% from 2024 to 2026, and its adjusted net profit will increase by 0.8%/11.1%/13.4% respectively.
CICC: Gradually filling the gap between inflation and demand will be the direction of economic work next year. The Central Economic Work Conference will be held in Beijing from December 11th to 12th. The research department of CICC believes that for the economic goal of next year, after "maintaining stable economic growth", the meeting proposed to "maintain overall stability in employment and prices" and put forward "focusing on goal guidance and striving to achieve an optimal combination of stable growth, stable employment and reasonable price recovery". This is the first time in the past 15 years that "stabilizing prices" has been taken as the goal of annual economic work during the period of low prices. The research department of CICC believes that gradually bridging the inflation gap and demand gap will be the direction of economic work next year.China Merchants Ping 'an Assets established the No.2 Investment Center for Intelligent Calculation. According to the enterprise search APP, recently, Shenzhen Zhaoping Intelligent Calculation No.2 Investment Center (Limited Partnership) was established with a capital contribution of 300 million yuan, and its business scope includes: engaging in investment activities with its own funds. Enterprise equity penetration shows that the enterprise is indirectly wholly-owned by Shenzhen Merchants Ping An Asset Management Co., Ltd.Institution: In the third quarter, the price and shipment of the large-capacity enterprise-level solid-state disk industry rose simultaneously. According to the latest survey of TrendForce Jibang Consulting, the strong demand for AI applications continued to drive the growth of the Enterprise SSD industry in the third quarter of 2024. As the supplier's shipment could not meet the market demand, the price rose, pushing up the overall revenue of the industry by nearly 30%. Due to the arrival of NVIDIA (NVIDIA) H series products, and the peak demand for Training AI Server, especially the strong demand for large-capacity products, the overall purchase order capacity increased by 15% quarter.
Strategy guide
Strategy guide
12-14
Strategy guide 12-14
Strategy guide
12-14
Strategy guide 12-14